tolperisone has been researched along with Dyskinesia Syndromes in 6 studies
Tolperisone: A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1211)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benecke, R | 1 |
| Patejdl, R | 1 |
| Perényi, G | 2 |
| Gálos, G | 1 |
| Dömötör, E | 1 |
| Huber, L | 1 |
2 reviews available for tolperisone and Dyskinesia Syndromes
| Article | Year |
|---|---|
[New therapies for spastic movement disorders].
Topics: Administration, Oral; Baclofen; Botulinum Toxins, Type A; Cannabinoids; Clonidine; Diazepam; Humans; | 2009 |
Observations with intensive Mydocalm treatment in neurological cases.
Topics: Humans; Movement Disorders; Nervous System Diseases; Propiophenones; Tolperisone | 1987 |
1 trial available for tolperisone and Dyskinesia Syndromes
| Article | Year |
|---|---|
Several years observations with Mydocalm muscle relaxant in locomotor disease patients.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Drug Therapy, Combi | 1992 |
3 other studies available for tolperisone and Dyskinesia Syndromes
| Article | Year |
|---|---|
Combined drug treatment of neurological inflammatory processes.
Topics: Adult; Aged; Drug Therapy, Combination; Humans; Middle Aged; Movement Disorders; Neuritis; Nicotinic | 1981 |
Intensive postoperative mydeton therapy of traumatological patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Contracture; Female; Humans; Male; Middle Aged; M | 1989 |
Observations with higher Mydocalm doses in outpatients of the surgical department.
Topics: Extremities; Humans; Movement Disorders; Muscle Spasticity; Propiophenones; Regional Blood Flow; Tol | 1986 |